Insect infection model for Campylobacter jejuni reveals that O-methyl phosphoramidate has insecticidal activity

Journal of Infectious Diseases

Volumn 201, Issue 5, 2010, Pages 776-782

  Champion, Olivia L ^a   Karlyshev, Andrey V ^b   Senior, Nicola J ^a   Woodward, Martin ^d   La Ragione, Roberto ^d   Howard, Sarah L ^c   Wren, Brendan W ^c   Titball, Richard W ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

O METHYL PHOSPHORAMIDATE; PHOSPHORAMIDIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM MUTANT; CAMPYLOBACTER JEJUNI; CAMPYLOBACTERIOSIS; GALLERIA MELLONELLA; INSECT; INSECTICIDAL ACTIVITY; LARVA; NONHUMAN; PRIORITY JOURNAL;

AMIDES; ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DISEASE MODELS, ANIMAL; GENE KNOCKOUT TECHNIQUES; HUMANS; LARVA; MOTHS; PHOSPHORIC ACIDS; SURVIVAL ANALYSIS; TEMPERATURE; VIRULENCE; VIRULENCE FACTORS;

EID: 76449093065     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/650494     Document Type: Article

References (44)

1. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001; 32:1201-1206.
2. Peterson MC. Clinical aspects of Campylobacter jejuni infections in adults. West J Med 1994; 161:148-152.
3. Janssen R, Krogfelt KA, Cawthraw SA, van Pelt W, Wagenaar JA, Owen RJ. Host-pathogen interactions in Campylobacter infections: the host perspective. Clin Microbiol Rev 2008; 21:505-518.
4. Spiller RC. Role of infection in irritable bowel syndrome. J Gastroenterol 2007; 42(Suppl 17):41-47.
5. Zheng J, Meng J, Zhao S, Singh R, Song W. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Tolllike receptor-mediated activation of NF-kappaB. Infect Immun 2008; 76:4498-4508.
6. Bacon DJ, Szymanski CM, Burr DH, Silver RP, Alm RA, Guerry P. A phase-variable capsule is involved in virulence of Campylobacter jejuni 81-176. Mol Microbiol 2001; 40:769-777.
7. Louwen R, Heikema A, van Belkum A, et al. The sialylated lipooligosaccharide outer core in Campylobacter jejuni is an important determinant for epithelial cell invasion. Infect Immun 2008; 76:4431-4438.
8. Guerry P, Ewing CP, Schirm M, et al. Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol 2006; 60:299-311.
9. Karlyshev AV, Wren BW. Development and application of an insertional system for gene delivery and expression in Campylobacter jejuni. Appl Environ Microbiol 2005; 71:4004-4013.
10. Davis L, Young K, DiRita V. Genetic manipulation of Campylobacter jejuni. Curr Protoc Microbiol 2008; 8:8A.2.1-8A.2.17.
11. Fox JG, Ackerman JI, Taylor N, Claps M, Murphy JC. Campylobacter jejuni infection in the ferret: an animal model of human campylobacteriosis. Am J Vet Res 1987; 48:85-90.
12. Babakhani FK, Bradley GA, Joens LA. Newborn piglet model for campylobacteriosis. Infect Immun 1993; 61:3466-3475.
13. Wassenaar TM, van der Zeijst BA, Ayling R, Newell DG. Colonization of chicks by motility mutants of Campylobacter jejuni demonstrates the importance of flagellin A expression. J Gen Microbiol 1993; 139(Pt 6):1171-1175.
14. Karlyshev AV, Everest P, Linton D, Cawthraw S, Newell DG, Wren BW. The Campylobacter jejuni general glycosylation system is important for attachment to human epithelial cells and in the colonization of chicks. Microbiology 2004; 150:1957-1964.
15. Nachamkin I, Yang XH, Stern NJ. Role of Campylobacter jejuni flagella as colonization factors for three-day-old chicks: analysis with flagellar mutants. Appl Environ Microbiol 1993; 59:1269-1273.
16. Newell DG. Animal models of Campylobacter jejuni colonization and disease and the lessons to be learned from similar Helicobacter pylori models. Symp Ser Soc Appl Microbiol 2001; (30):57S-67S.
17. Champion OL, Valdez Y, Thorson L, et al. A murine intraperitoneal infection model reveals that host resistance to Campylobacter jejuni is Nramp1 dependent. Microbes Infect 2008; 10:922-927.
18. Chang C, Miller JF. Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun 2006; 74:5261-5271.
19. Mansfield LS, Patterson JS, Fierro BR, et al. Genetic background of IL-10-/- mice alters host-pathogen interactions with Campylobacter jejuni and influences disease phenotype. Microb Pathog 2008; 45: 241-257
20. Watson RO, Novik V, Hofreuter D, Lara-Tejero M, Galan JE. AMyD88- deficient mouse model reveals a role for Nramp1 in Campylobacter jejuni infection. Infect Immun 2007; 75:1994-2003.
21. Darby C. Interactions with microbial pathogens. WormBook 2005; 6: 1-15.
22. Peleg AY, Jara S, Monga D, Eliopoulos GM, Moellering RC Jr, Mylonakis E. Galleria mellonella as a model system to study Acinetobacter baumannii pathogenesis and therapeutics. Antimicrob Agents Chemother 2009; 53:2605-2609.
23. Mylonakis E, Casadevall A, Ausubel FM. Exploiting amoeboid and nonvertebrate animal model systems to study the virulence of human pathogenic fungi. PLoS Pathog 2007; 3:e101.
24. Bergin D, Reeves EP, Renwick J, Wientjes FB, Kavanagh K. Superoxide production in Galleria mellonella hemocytes: identification of proteins homologous to the NADPH oxidase complex of human neutrophils. Infect Immun 2005; 73:4161-4170.
25. Lavine MD, Strand MR. Insect hemocytes and their role in immunity. Insect Biochem Mol Biol 2002; 32:1295-1309.
26. Aperis G, Fuchs BB, Anderson CA, Warner JE, Calderwood SB, Mylonakis E. Galleria mellonella as a model host to study infection by the Francisella tularensis live vaccine strain. Microbes Infect 2007; 9: 729-734.
27. Schell MA, Lipscomb L, DeShazer D. Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei. J Bacteriol 2008; 190:2306-2313.
28. Jander G, Rahme LG, Ausubel FM. Positive correlation between virulence of Pseudomonas aeruginosa mutants in mice and insects. J Bacteriol 2000; 182:3843-3845.
29. Mylonakis E, Moreno R, El Khoury JB, et al. Galleria mellonella as a model system to study Cryptococcus neoformans pathogenesis. Infect Immun 2005; 73:3842-3850.
30. Brennan M, Thomas DY, Whiteway M, Kavanagh K. Correlation between virulence of Candida albicans mutants in mice and Galleria mellonella larvae. FEMS Immunol Med Microbiol 2002; 34:153-157.
31. Jones MA, Marston KL, Woodall CA, et al. Adaptation of Campylobacter jejuni NCTC11168 to high-level colonization of the avian gastrointestinal tract. Infect Immun 2004; 72:3769-3776.
32. Korlath JA, Osterholm MT, Judy LA, Forfang JC, Robinson RA. A point-source outbreak of campylobacteriosis associated with consumption of raw milk. J Infect Dis 1985; 152:592-596.
33. Karlyshev AV, Wren BW. Detection and initial characterization of novel capsular polysaccharide among diverse Campylobacter jejuni strains using Alcian blue dye. J Clin Microbiol 2001; 39:279-284.
34. Oldfield NJ, Moran AP, Millar LA, Prendergast MM, Ketley JM. Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent. J Bacteriol 2002; 184:2100-2107.
35. Howard SL, Jagannathan A, Soo EC, et al. Campylobacter jejuni glycosylation island important in cell charge, legionaminic acid biosynthesis, and colonisation of chickens. Infect Immun 2009; 77(6):2544-2556.
36. McNally DJ, Lamoureux MP, Karlyshev AV, et al. Commonality and biosynthesis of the O-methyl phosphoramidate capsule modification in Campylobacter jejuni. J Biol Chem 2007; 282:28566-28576.
37. Parkhill J, Wren BW, Mungall K, et al. The genome sequence of the food-borne pathogen Campylobacter jejuni reveals hypervariable sequences. Nature 2000; 403:665-668.
38. Nappi AJ, Christensen BM. Melanogenesis and associated cytotoxic reactions: applications to insect innate immunity. Insect Biochem Mol Biol 2005; 35:443-459.
39. Jain D, Prasad KN, Sinha S, Husain N. Differences in virulence attributes between cytolethal distending toxin positive and negative Campylobacter jejuni strains. J Med Microbiol 2008; 57:267-272.
40. Lara-Tejero M, Galan JE. A bacterial toxin that controls cell cycle progression as a deoxyribonuclease I-like protein. Science 2000; 290: 354-357.
41. Konkel ME, Klena JD, Rivera-Amill V, et al. Secretion of virulence proteins from Campylobacter jejuni is dependent on a functional flagellar export apparatus. J Bacteriol 2004; 186:3296-3303.
42. Song YC, Jin S, Louie H, et al. FlaC, a protein of Campylobacter jejuni TGH9011 (ATCC43431) secreted through the flagellar apparatus, binds epithelial cells and influences cell invasion. Mol Microbiol 2004; 53: 541-553.
43. Poly F, Ewing C, Goon S, et al. Heterogeneity of a Campylobacter jejuni protein that is secreted through the flagellar filament. Infect Immun 2007; 75:3859-3867.
44. Guerry P, Szymanski CM, Prendergast MM, et al. Phase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitro. Infect Immun 2002; 70:787-793.